Evidence for a Common Non‐Heme Chelatable‐Iron‐Dependent Activation Mechanism for Semisynthetic and Synthetic Endoperoxide Antimalarial Drugs

The iron‐y of fate: Isobole analyses of fluorescently labeled antimalarial endoperoxides with chelators selective for non‐heme iron, and laser confocal microscopy studies within living malaria parasites have shown that the semisynthetic analogues of artemisinin and synthetic endoperoxides (see examp...

Full description

Saved in:
Bibliographic Details
Published inAngewandte Chemie International Edition Vol. 46; no. 33; pp. 6278 - 6283
Main Authors Stocks, Paul A., Bray, Patrick G., Barton, Victoria E., Al‐Helal, Mohammed, Jones, Michael, Araujo, Nuna C., Gibbons, Peter, Ward, Stephen A., Hughes, Ruth H., Biagini, Giancarlo A., Davies, Jill, Amewu, Richard, Mercer, Amy E., Ellis, Gemma, O'Neill, Paul M.
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag 01.01.2007
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The iron‐y of fate: Isobole analyses of fluorescently labeled antimalarial endoperoxides with chelators selective for non‐heme iron, and laser confocal microscopy studies within living malaria parasites have shown that the semisynthetic analogues of artemisinin and synthetic endoperoxides (see example) share a common mechanism of action involving chelatable‐iron‐mediated bioactivation (see images) and irreversible alkylation of parasite targets.
Bibliography:This work was supported by grants from the BBSRC (UK) (P.A.S., P.O.N., P.G.B., V.B., M.J., S.A.W.; BB/C006321/1, BBS/B/05508, BBS/Q/Q/2004/06032, and BBS/S/P/2003/10353), Romark, Florida (R.A.), and in part by the EU (Antimal. FP6 Malaria Drugs Initiative).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.200604697